Home Cart Sign in  
Chemical Structure| 15164-44-0 Chemical Structure| 15164-44-0
Chemical Structure| 15164-44-0

*Storage: Keep in dark place,Sealed in dry,Room Temperature.

*Shipping: Normal

4-Iodobenzaldehyde

CAS No.: 15164-44-0

4.5 *For Research Use Only !

Cat. No.: A211346 Purity: 98%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
1g łÇͶÊÊ In Stock In Stock Login
5g łÇď¶ÊÊ In Stock In Stock Login
10g łËǶÊÊ In Stock In Stock Login
25g łÍʶÊÊ In Stock In Stock Login
100g łÇ§Ë¶ÊÊ In Stock In Stock Login
500g łòÿó¶ÊÊ In Stock In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 1g

    łÇͶÊÊ

  • 5g

    łÇď¶ÊÊ

  • 10g

    łËǶÊÊ

  • 25g

    łÍʶÊÊ

  • 100g

    łÇ§Ë¶ÊÊ

  • 500g

    łòÿó¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 15164-44-0 ]

CAS No. :15164-44-0
Formula : C7H5IO
M.W : 232.02
SMILES Code : C1=C(C=CC(=C1)I)C=O
MDL No. :MFCD00039576
Boiling Point : No data available
InChI Key :NIEBHDXUIJSHSL-UHFFFAOYSA-N
Pubchem ID :96657

Safety of [ 15164-44-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 15164-44-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 44.55
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

17.07 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.69
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.48
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.1
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.37
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.97
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.32

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.27
Solubility 0.125 mg/ml ; 0.000539 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.48
Solubility 0.763 mg/ml ; 0.00329 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.3
Solubility 0.115 mg/ml ; 0.000498 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.95 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.57

Application In Synthesis [ 15164-44-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 15164-44-0 ]

[ 15164-44-0 ] Synthesis Path-Downstream   1~18

  • 2
  • [ 626-44-8 ]
  • [ 15164-44-0 ]
  • [ 212791-03-2 ]
  • 3
  • [ 15164-44-0 ]
  • [ 1979-98-2 ]
  • 5,5'-(4-iodobenzylidene)bis(4,6-dihydroxy-2-methylthiopyrimidine) [ No CAS ]
  • 4
  • [ 15164-44-0 ]
  • [ 35674-27-2 ]
  • 5
  • [ 15164-44-0 ]
  • [ 58123-72-1 ]
  • 6
  • [ 18628-07-4 ]
  • [ 15164-44-0 ]
  • [ 1014608-07-1 ]
  • 7
  • [ 18628-07-4 ]
  • [ 15164-44-0 ]
  • [ 1009639-02-4 ]
  • 8
  • [ 86-74-8 ]
  • [ 15164-44-0 ]
  • [ 110677-45-7 ]
YieldReaction ConditionsOperation in experiment
25% With copper(I) oxide; In N,N-dimethyl acetamide; at 190℃; for 72h; A DMAc solution (60 mL) of 4-iodobenzaldehyde (3.48 g,15.00 mmol), carbazole (3.01 g, 18.00 mmol), and copper(I) oxide (2.57 g, 18.00 mmol) was stirred at 190 Cfor 3 days. After cooling to room temperature, the productmixture was washed with water. After removal ofthe organic solvent, the residue was purified by columnchromatography on silica gel using methylene chlorideand n-hexane (1:5, v/v) as an eluent. Further purificationwas performed by precipitation in n-hexane to obtain1 as a light yellow solid. Yield (1.02 g, 25%). mp160-162 C. 1H NMR (400 MHz, DMSO-d6) 7.33(t, 2 H, -Ph-carbazole), 7.46 (t, 3 H, -Ph-carbazole),7.52 (d, 2 H, -Ph-carbazole), 7.91 (d, 2 H, -carbazole-Ph), 8.20 (d, 2 H, -carbazole-Ph), 8.27 (d, 2 H, -Ph-carbazole), 10.12 (s, 1 H, -Ph-CHO); 13C NMR(100.64 MHz, DMSO-d6) 100.86, 120.67, 120.78,123.24, 126.53, 126.72, 131.41, 134.58, 139.45, 142.20,192.23.
  • 9
  • [ 1365889-00-4 ]
  • [ 101335-11-9 ]
  • [ 15164-44-0 ]
  • [ 1365889-09-3 ]
  • (Z)-4-(2-(2-chloro-4-fluorophenyl)-1-(1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)but-1-en-1-yl)benzaldehyde [ No CAS ]
YieldReaction ConditionsOperation in experiment
Example 35Preparation of Compound 110: (E)-Ethyl 3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylate hydrochlorideStep 1: (E)-4-(2-(2-Chloro-4-fluorophenyl)-1-(1-(tetrahydro-2H-pyran-2-yl)-1,1-indazol-5-yl)but-1-en-1-yl)benzaldehyde A round-bottom flask equipped with a magnetic stir bar, a reflux condenser, internal thermometer, and a N2 inlet was charged with 5-(but-1-yn-1-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole (50.0 g, 197 mmol; Intermediate 3), bis(pinacolato)diboron (50.4 g, 199 mmol), and anhydrous 2-methyltetrahydrofuran (393 mL) followed by Pt(PPh3)4 (1.83 g, 1.5 mmol). This mixture was degassed with three vacuum/N2 cycles, heated at 83 C. (internal temperature; oil bath at 95 C.) for 5 h under N2, and then allowed to cool to room temperature. 2-Methyltetrahydrofuran (393 mL), cesium carbonate (128.1 g, 393 mmol), and water (11.8 mL, 1.5% v/v) were added, and the reaction was cooled to 4 C. 4-Iodobenzaldehyde (45.6 g, 197 mmol) and PdCl2(PPh3)2 (6.90 g, 9.8 mmol) were added, and the reaction was degassed with three vacuum/N2 cycles. The mixture was allowed to warm to room temperature and stirred overnight. Aqueous KOH solution (4M, 275 mL, 1100 mmol) and <strong>[101335-11-9]2-chloro-4-fluoroiodobenzene</strong> (70.6 g, 275 mmol) were added. The reaction was degassed with 3 vacuum/N2 cycles, heated at 75 C. (internal temperature; oil bath at 90 C.) for 7 h under N2, and then allowed to cool to room temperature. The layers were separated, and the organic layer was washed with brine (800 mL), dried over sodium sulfate, filtered, and concentrated. The crude product was purified by silica gel chromatography (0-20% ethyl acetate in hexanes) to give the title compound (82.6 g, 7:1 mixture of regioisomers) as a pale yellow foam. Data for major isomer; (E)-4-(2-(2-chloro-4-fluorophenyl)-1-(1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)but-1-en-1-yl)benzaldehyde: 1H NMR (300 MHz, DMSO-d6): delta 9.82 (s, 1H), 8.15 (s, 1H), 7.78-7.71 (m, 2H), 7.61 (d, 2H), 7.43-7.27 (m, 3H), 7.15 (m, 3H), 5.86 (dd, 1H), 3.93-3.85 (m, 1H), 3.79-3.68 (m, 1H), 2.44-2.36 (m, 3H), 2.10-1.96 (m, 2H), 1.81-1.67 (m, 1H), 1.63-1.53 (m, 2H), 0.92 (t, 3H); LCMS: 405 [(M-THP+H)+H]+.
  • 10
  • [ 34966-49-9 ]
  • [ 16433-96-8 ]
  • [ 15164-44-0 ]
  • [ 1360002-05-6 ]
  • 11
  • [ 111291-97-5 ]
  • [ 15164-44-0 ]
  • tert-butyl 4-((4-formylphenyl)ethynyl)benzoate [ No CAS ]
  • 12
  • [ 5720-06-9 ]
  • [ 15164-44-0 ]
  • [ 421553-62-0 ]
  • 13
  • [ 873-55-2 ]
  • [ 15164-44-0 ]
  • [ 66-39-7 ]
  • 14
  • [ 1679-18-1 ]
  • [ 15164-44-0 ]
  • [ 80565-30-6 ]
  • 15
  • [ 110-00-9 ]
  • [ 15164-44-0 ]
  • [ 60456-77-1 ]
  • 16
  • [ 62-53-3 ]
  • [ 15164-44-0 ]
  • [ 446065-11-8 ]
  • N-(cyclohexyl(4-iodophenyl)methyl)aniline [ No CAS ]
  • 17
  • [ 1798-06-7 ]
  • [ 18282-51-4 ]
  • [ 15164-44-0 ]
  • 18
  • [ 780-69-8 ]
  • [ 15164-44-0 ]
  • [ 66-39-7 ]
 

Related Products

Technical Information

• Alkyl Halide Occurrence • Barbier Coupling Reaction • Baylis-Hillman Reaction • Benzylic Oxidation • Birch Reduction • Blanc Chloromethylation • Bucherer-Bergs Reaction • Clemmensen Reduction • Complex Metal Hydride Reductions • Corey-Chaykovsky Reaction • Corey-Fuchs Reaction • Fischer Indole Synthesis • Friedel-Crafts Reaction • General Reactivity • Grignard Reaction • Hantzsch Dihydropyridine Synthesis • Henry Nitroaldol Reaction • Hiyama Cross-Coupling Reaction • Horner-Wadsworth-Emmons Reaction • Hydride Reductions • Hydrogenolysis of Benzyl Ether • Julia-Kocienski Olefination • Kinetics of Alkyl Halides • Knoevenagel Condensation • Leuckart-Wallach Reaction • McMurry Coupling • Meerwein-Ponndorf-Verley Reduction • Mukaiyama Aldol Reaction • Nozaki-Hiyama-Kishi Reaction • Passerini Reaction • Paternò-Büchi Reaction • Petasis Reaction • Pictet-Spengler Tetrahydroisoquinoline Synthesis • Preparation of Aldehydes and Ketones • Preparation of Alkylbenzene • Preparation of Amines • Prins Reaction • Reactions of Aldehydes and Ketones • Reactions of Alkyl Halides with Reducing Metals • Reactions of Amines • Reactions of Benzene and Substituted Benzenes • Reactions of Dihalides • Reformatsky Reaction • Schlosser Modification of the Wittig Reaction • Schmidt Reaction • Stetter Reaction • Stobbe Condensation • Substitution and Elimination Reactions of Alkyl Halides • Suzuki Coupling • Tebbe Olefination • Ugi Reaction • Vilsmeier-Haack Reaction • Wittig Reaction • Wolff-Kishner Reduction

Categories

Related Functional Groups of
[ 15164-44-0 ]

Aryls

Chemical Structure| 696-41-3

A135649 [696-41-3]

3-Iodobenzaldehyde

Similarity: 0.97

Chemical Structure| 26260-02-6

A187888 [26260-02-6]

2-Iodobenzaldehyde

Similarity: 0.89

Chemical Structure| 13329-40-3

A344622 [13329-40-3]

1-(4-Iodophenyl)ethanone

Similarity: 0.89

Chemical Structure| 31970-26-0

A103357 [31970-26-0]

1-(4-Iodophenyl)propan-1-one

Similarity: 0.87

Chemical Structure| 14452-30-3

A190182 [14452-30-3]

1-(3-Iodophenyl)ethanone

Similarity: 0.87

Aldehydes

Chemical Structure| 696-41-3

A135649 [696-41-3]

3-Iodobenzaldehyde

Similarity: 0.97

Chemical Structure| 26260-02-6

A187888 [26260-02-6]

2-Iodobenzaldehyde

Similarity: 0.89

Chemical Structure| 861118-00-5

A157263 [861118-00-5]

3,5-Diiodo-4-methylbenzaldehyde

Similarity: 0.85

Chemical Structure| 90151-01-2

A102261 [90151-01-2]

4-Hydroxy-2-iodobenzaldehyde

Similarity: 0.75

Chemical Structure| 188813-09-4

A179901 [188813-09-4]

3-Bromo-5-iodobenzaldehyde

Similarity: 0.73